Replies to post #1468 on Innovus Pharmaceuticals Inc. (fka INNV)

[Honeycomb777]

Let's be extremely conservative here and say 2016 revs come in at 3m... Then the low end of PPS would approx 12-14 cents even if not approved. If Fluticare is approved, it will likely bring revenues between 50-55m after one full year. If market is 6-8 months forward looking, then 1.10 is your number heading towards 2.20 6 months after approval. Then P/E ratio will be more clear and a buyout would reflect a higher multiple. Could go 7 ish if sales are better than expected. Excited about what BH revs bring in near term as well